GlassScriptPhysician profile
Robbie Sheppard
NPI 1629515788
$833.61
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $51.88 · 2023: $349 · 2024: $114 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $240.99 | 2021-2025 | Xtampza |
| Abbott Laboratories | $163.51 | 2021-2023 | Proclaim |
| Averitas Pharma INC. | $109.99 | 2023 | Qutenza |
| Protega Pharmaceutials INC | $108.30 | 2022-2023 | Roxybond |
| Abbvie INC. | $51.10 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $38.31 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.34 | 2024 | Exparel, Zilretta, Iovera |
| Redhill Biopharma INC. | $22.00 | 2021 | |
| Scilex Pharmaceuticals INC. | $18.28 | 2021 | |
| Medtronic, INC. | $17.10 | 2021 | |
| Boston Scientific Corporation | $16.91 | 2025 | Spectra Wavewriter |
| Biodelivery Sciences International, INC. | $13.30 | 2021 | |
| Ibsa Pharma INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robbie Sheppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.